PEA supplement shows promise for chronic back pain in new trial
NCT ID NCT06694337
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tested whether a dietary supplement called palmitoylethanolamide (PEA) can reduce nerve-related low back pain. 120 adults with chronic pain took either a low or high dose of PEA or a placebo for several weeks. Researchers measured pain intensity, disability, and quality of life to see if PEA helps more than a dummy pill.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Palmitoylethanolamide (PEA) supplement
- What this could lead to
- If it works, this could offer a natural supplement option to help ease nerve-related low back pain.
- What could go wrong
- This is a small, completed trial with no phase designation, so results may not be strong enough to recommend PEA widely. Supplements can have variable effects and may not work for everyone.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LOW BACK PAIN are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lady Reading Hospital
Peshawar, Pakistan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a smartphone app hypnotize away back pain?
- Can a mind-body combo ease chronic back pain and sleeplessness?
- Water workouts could be the key to back pain relief
- Can education boost exercise compliance for chronic pain sufferers?
- Which exercise wins for Athletes' back pain? a Head-to-Head test
- Brain-Boosting Warm-Ups may sharpen balance in back pain sufferers